Shanghai, China – On November 17, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") was listed as "2016 Shanghai Science and Technology Little Giant Enterprise (for Cultivation)" by Science and Technology Commission of Shanghai Municipality and Shanghai Municipal Commission of Economy and Informatization. The selected companies will gain funding from city or district (county) governments based on the companies' independent innovation plans. Founded in 2010 in Shanghai, MicroPort EP primarily focus on the development, manufacture, and marketing of the interventional medical devices respectively for the treatment of electrophysiological diseases. MicroPort® EP devices are widely used in China's top hospitals and have been exported to many overseas countries and regions. MicroPort EP selected as 2015 Shanghai High- and New-Technology Enterprises.
Under the direction of Science and Technology Commission of Shanghai Municipality and Shanghai Municipal Commission of Economy and Informatization, the Science and Technology Little Giant Project aims to provide support to unlisted high-tech SMEs (small- and medium-sized enterprises) registered in Shanghai so as to foster the strategic and emerging industries such as information technology, smarter healthcare and bio-tech industries. The candidate has to meet strict requirements regarding the percentage of its R&D headcount, its R&D expenses in recent three fiscal years, its major business revenue in the previous year, the average growth rate of its revenue or net profit in the previous three years, management team and finical regulations. It will be further assessed through oral defense and online review before eventually be selected as "2016 Shanghai Science and Technology Little Giant Enterprise."